These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 9210702)

  • 1. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
    Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
    Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of continuous 5-FU infusion and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric and colorectal adenocarcinomas.
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():528-34. PubMed ID: 10895205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer.
    Kim R; Murakami S; Ohi Y; Inoue H; Yoshida K; Toge T
    Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma.
    Tanioka H; Tsuji A; Morita S; Horimi T; Takamatsu M; Shirasaka T; Mizushima T; Ochi K; Kiura K; Tanimoto M
    Anticancer Res; 2003; 23(2C):1891-7. PubMed ID: 12820474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemotherapy in high-grade advanced gastric cancer with protracted infusional 5-fluorouracil and consecutive low-dose cisplatin].
    Kondo K; Murase M; Yokoyama Y; Kato J; Hibi K; Kasai Y; Akiyama S; Ito K; Takagi H
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1299-303. PubMed ID: 8831742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical effect of low-dose FP (5-FU + low-dose CDDP) in patients with far advanced gastric cancer, and their quality of life].
    Murakami S; Yoshida K; Kin R; Nishimoto N; Kagawa Y; Yano Y; Nishiyama M; Hirai T; Toge T
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):853-8. PubMed ID: 10897211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of adjuvant chemotherapy using 5-fluorouracil, leucovorin and cis-diamminedichloroplatinum for patients with advanced and recurrent gastric cancer].
    Katsumata K; Yamamoto K; Ohno M; Shibata K; Yamashita S; Moriwaki R; Kohno M; Tadatomo H; Koyanagi Y
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):309-14. PubMed ID: 9051133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination chemotherapy of 5-fluorouracil and cisplatin against advanced gastric cancer.
    Imada T; Sairenji M; Suda T; Yamamoto Y; Amano T; Motohashi H
    Hepatogastroenterology; 1999; 46(25):594-600. PubMed ID: 10228867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
    Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
    Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma.
    Kim YH; Shin SW; Kim BS; Kim JH; Kim JG; Mok YJ; Kim CS; Rhyu HS; Hyun JH; Kim JS
    Cancer; 1999 Jan; 85(2):295-301. PubMed ID: 10023695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of continuous infusion of 5-fluorouracil and daily low-dose cisplatin for inoperable recurrent cancer of the stomach and colon].
    Satoh Y; Une Y; Fujisawa J; Sawaguchi Y; Muranaga S; Obara M; Uchino J
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):87-92. PubMed ID: 7826083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.